Literature DB >> 10672353

[Inadvertent potassium chloride infusion in an epidural catheter].

P J Kulka1, I Stratesteffen, R Grünewald, A Wiebalck.   

Abstract

In a 65 years old male patient 38 cc of a 7.45% potassium chloride-solution was inadvertently infused within 3 hours into an epidural catheter on the first postoperative day. The epidural potassium chloride administration resulted in a paresis and painful paraesthesia of the patient's legs and a level of sensory blockade to TH 11. Furthermore vegetative symptoms like hypertension and tachycardia were observed. For therapy a single bolus of 40 mg dexamethasone was administered intravenously followed by an epidural infusion of sodium chloride 0.9% 99 cc/h for several hours. About 6 hours after the start of infusion all symptoms had disappeared. It is proposed that the use of colour-coded epidural catheter devices and coloured electrolyte solutions as well as infusion-pumps with a larger reservoir that reduce the frequency of syringe changes would be helpful in avoiding such complications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10672353     DOI: 10.1007/s001010050803

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  3 in total

1.  Acute transient spinal paralysis and cardiac symptoms following an accidental epidural potassium infusion - a case report.

Authors:  Martin Kreutzträger; Marcel A Kopp; Thomas Liebscher
Journal:  BMC Anesthesiol       Date:  2017-10-06       Impact factor: 2.217

2.  Inadvertent administration of potassium chloride in the epidural space: How to prevent the inevitable.

Authors:  Jasmeet Kaur; Adarsh C Swami; Ashwini Sharma; Kanika Arora
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2019 Jan-Mar

Review 3.  Neuraxial and peripheral misconnection events leading to wrong-route medication errors: a comprehensive literature review.

Authors:  Eugene R Viscusi; Vincent Hugo; Klaus Hoerauf; Frederick S Southwick
Journal:  Reg Anesth Pain Med       Date:  2020-11-03       Impact factor: 6.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.